Literature DB >> 3934907

Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.

B Brenner, J Green, H Rosenbaum, Y Ben Arieh, A Nagler, I Tatarsky.   

Abstract

A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3934907     DOI： 10.1159/000206163

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


  2 in total

Review 1.  Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.

Authors:  Yasunobu Sekiguchi; Syuichi Shirane; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 2.  Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.

Authors:  Yasunobu Sekiguchi; Nana Matsuzawa; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Kouji Izutsu; Kengo Takeuchi; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Hematol       Date:  2013-07-12       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.